跳至主要内容
临床试验/IRCT20100126003181N4
IRCT20100126003181N4尚未招募3 期

Effect of Riluzole on cognitive function of patients with mild Alzheimers disease: a double-blind randomized clinical trial, placebo-controlled

Tehran University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
60 years 至 80 years(—)
性别
All

入选标准

  • Having of mild type of Alzheimer's Disease
  • Receiving one of the anticholinesterase drugs for treating Alzheimer's from three months ago
  • aged between 60-80

排除标准

  • Having any other type of Dementia
  • Any history of using Memantine or Riluzole
  • History of using medications with glutamatergic interaction
  • History of alcohol and opium abuse
  • History of diseases such as Parkinson's disease, epilepsy, stroke, high blood pressure, uncontrolled diabetes, MS, mental retardation, CNS tumors, Huntington, subdural Hematoma, history of major psychiatric diseases
  • History of severe head trauma that results in loss of consciousness

研究者

相似试验

Effect of Riluzole on Alzheimer's Disease | 临床试验